Evidence map›Paper›PMID 39659462›Full record

ArticleEuropean heart journal. Case reports2024

Aortoesophageal fistula 19 years after radiotherapy for oesophageal cancer: a case report.

Satoshi Sakakibara, Akira Marumoto

Abstract readCase Reports
In one paragraph

Article in European heart journal. Case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Satoshi SakakibaraDepartment of Cardiovascular Surgery, Higashiosaka City Medical Center, 3-4-5, Nishiiwata, Higashiosaka, Osaka 578-8588, Japan.ORCID https://orcid.org/0009-0001-9322-4235
Akira MarumotoDepartment of Cardiovascular Surgery, Higashiosaka City Medical Center, 3-4-5, Nishiiwata, Higashiosaka, Osaka 578-8588, Japan.ORCID https://orcid.org/0000-0002-8354-4200

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Aortoesophageal fistula (AEF) is a life-threatening disease that causes massive bleeding, sepsis, and ultimately death. Therefore, emergency treatments are required. Recently, cases of AEF treated with thoracic endovascular aortic repair (TEVAR) have been reported. Case summary: An 84-year-old man was referred to a local hospital with massive haematemesis and transient loss of consciousness. The patient's medical history included radiotherapy for oesophageal cancer 19 years before presentation. Gastrofiberscopy revealed an ulcer in the thoracic oesophagus and no recurrence of oesophageal cancer. Computed tomography (CT) showed that the same area was adjacent to the thoracic aorta and that there was no thoracic aortic aneurysm. The patient was then transferred to our institution for surgical treatment. We diagnosed the patient with an AEF caused by radiotherapy of the oesophagus. Therefore, TEVAR was performed. Due to the patient's advanced age, condition, and the possibility of strong adhesions, there was a high risk that they would be unable to tolerate oesophagectomy to prevent stent graft infection. Therefore, antibiotic therapy was initiated. However, CT revealed a stent graft infection 24 days after TEVAR. The patient died of sepsis 27 days after the procedure. Discussion: We describe the first case of AEF as a very late complication of radiotherapy for oesophageal cancer. Surgery to repair oesophageal defects is necessary to prevent stent graft infection. However, the decision for such surgery should be made on a case-by-case basis, taking into account the patient's condition and ability to tolerate the procedure.

Indexed as

Aortoesophageal fistulaCase reportOesophageal cancerRadiotherapy

Identifiers

PMID39659462
PMCPMC11630008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.